1. Inicio
  2. Investigación
  3. Grupos de investigación
  4. Enfermedades Infecciosas

Enfermedades Infecciosas

Buscador de publicaciones

Sólo se han incluido artículos originales, editoriales y revisiones.

  • Berenguer J, Zamora FX, Aldámiz-Echevarría T, Von Wichmann MA, Crespo M, López-Aldeguer J, Carrero A, Montes M, Quereda C, Téllez MJ, Galindo MJ, Sanz J, Santos I, Guardiola JM, Barros C, Ortega E, Pulido F, Rubio R, Mallolas J, Tural C, Jusdado JJ, Pérez G, Díez C, Álvarez-Pellicer J, Esteban H, Bellón JM, González-García J.

    Comparison of the Prognostic Value of Liver Biopsy and FIB-4 Index in Patients Coinfected With HIV and Hepatitis C Virus

    CLINICAL INFECTIOUS DISEASES . 60(6): 950-958. Nº de citas: 38

    [doi:10.1093/cid/ciu939]

  • Shaw E, Miró JM, Puig-Asensio M, Pigrau C, Barcenilla F, Murillas J, Garcia-Pardo G, Espejo E, Padilla B, Garcia-Reyne A, Pasquau J, Rodriguez-Baño J, López-Contreras J, Montero M, de la Calle C, Pintado V, Calbo E, Gasch O, Montejo M, Salavert M, Garcia-Pais MJ, Carratalà J, Pujol M, Instituto de Salud Carlos III, Madrid, Spain.

    Daptomycin plus fosfomycin versus daptomycin monotherapy in treating MRSA: protocol of a multicentre, randomised, phase III trial

    BMJ Open . 5(3): . Nº de citas: 35

    [doi:10.1136/bmjopen-2014-006723]

  • Mocroft A, Lundgren JD, Ross M, Law M, Reiss P, Kirk O, Smith C, Wentworth D, Neuhaus J, Fux CA, Moranne O, Morlat P, Johnson MA, Ryom L, D:A:D study group, Royal Free Hospital Clinic Cohort, INSIGHT study group, SMART study group, ESPRIT study group.

    Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study

    PLOS MEDICINE . 12(3): . Nº de citas: 115

    [doi:10.1371/journal.pmed.1001809]

  • Valverde A, Turrientes MC, Norman F, San Martín E, Moreno L, Pérez-Molina JA, López-Vélez R, Cantón R.

    CTX-M-15-non-ST131 Escherichia coli isolates are mainly responsible of faecal carriage with ESBL-producing Enterobacteriaceae in travellers, immigrants and those visiting friends and relatives

    CLINICAL MICROBIOLOGY AND INFECTION . 21(3): . Nº de citas: 30

    [doi:10.1016/j.cmi.2014.09.021]

  • Shaw E, Benito N, Rodríguez-Baño J, Padilla B, Pintado V, Calbo E, Pallarés MA, Gozalo M, Ruiz-Garbajosa P, Horcajada JP.

    Risk factors for severe sepsis in community-onset bacteraemic urinary tract infection: Impact of antimicrobial resistance in a large hospitalised cohort

    JOURNAL OF INFECTION . 70(3): 247-254. Nº de citas: 17

    [doi:10.1016/j.jinf.2014.09.011]

  • Abad-Fernández M, Moreno A, Dronda F, del Campo S, Quereda C, Casado JL, Pérez-Elías MJ, Moreno S, Vallejo A.

    Delayed liver fibrosis in HTLV-2-infected patients co-infected with HIV-1 and hepatitis C virus with suppressive antiretroviral therapy

    AIDS . 29(4): 401-409. Nº de citas: 7

    [doi:10.1097/QAD.0000000000000555]

  • Lopez-Velez R, Palomar AM, Oteo JA, Norman FF, Pérez-Molina JA, Portillo A.

    Novel Candidatus Rickettsia Species Detected in Nostril Tick from Human, Gabon, 2014

    EMERGING INFECTIOUS DISEASES . 21(2): 325-327. Nº de citas: 8

    [doi:10.3201/eid2102.141048]

  • Vallejo A, Abad-Fernández M, Moreno S, Moreno A, Pérez-Elías MJ, Dronda F, Casado JL.

    High levels of CD4(+) CTLA-4(+) Treg cells and CCR5 density in HIV-1-infected patients with visceral leishmaniasis

    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES . 34(2): 267-275. Nº de citas: 16

    [doi:10.1007/s10096-014-2229-1]

  • Monge S, Díez M, Alvarez M, Guillot V, Iribarren JA, Palacios R, Delgado R, Jaén A, Blanco JR, Domingo P, Portilla J, Pérez Elías MJ, Garcia F.

    Use of cohort data to estimate national prevalence of transmitted drug resistance to antiretroviral drugs in Spain (2007-2012).

    CLINICAL MICROBIOLOGY AND INFECTION . 21(1): .

    [doi:10.1016/j.cmi.2014.08.007]

  • Alvarez M, Monge S, Chueca N, Guillot V, Viciana P, Anta L, Rodriguez C, Gomez-Sirvent JL, Navarro G, de los Santos I, Moreno S, García F.

    Transmitted drug resistance to rilpivirine in newly diagnosed antiretroviral naive adults.

    CLINICAL MICROBIOLOGY AND INFECTION . 21(1): .

    [doi:10.1016/j.cmi.2014.08.005]

  • Castells L, Rimola A, Manzardo C, Valdivieso A, Montero JL, Barcena R, Abradelo M, Xiol X, Aguilera V, Salcedo M, Rodriguez M, Bernal C, Suarez F, Antela A, Olivares S, Del Campo S, Laguno M, Fernandez JR, de la Rosa G, Agüero F, Perez I, González-García J, Esteban-Mur JI, Miro JM, FIPSE LT-HIV Investigators.

    Pegylated interferon plus ribavirin in HIV-infected patients with recurrent hepatitis C after liver transplantation: A prospective cohort study

    JOURNAL OF HEPATOLOGY . 62(1): 92-100. Nº de citas: 20

    [doi:10.1016/j.jhep.2014.07.034]

  • Abad-Fernández M, Gutiérrez C, Madrid N, Hernández-Novoa B, Díaz L, Muñoz-Fernández MA, Moreno S, Vallejo A.

    Expression of gut-homing beta 7 receptor on T cells: surrogate marker for microbial translocation in suppressed HIV-1-infected patients?

    HIV MEDICINE . 16(1): 15-23. Nº de citas: 1

    [doi:10.1111/hiv.12167]

  • Norman FF, Monge-Maillo B, Martínez-Pérez Á, Perez-Molina JA, López-Vélez R.

    Parasitic infections in travelers and immigrants: part II helminths and ectoparasites

    Future Microbiology . 10(1): 87-99. Nº de citas: 12

    [doi:10.2217/fmb.14.106]

  • Norman FF, Monge-Maillo B, Martínez-Pérez Á, Perez-Molina JA, López-Vélez R.

    Parasitic infections in travelers and immigrants: part I protozoa

    Future Microbiology . 10(1): 69-86. Nº de citas: 23

    [doi:10.2217/fmb.14.105]

  • Blanco JR, Jarrin I, Martinez A, Siles E, Larrayoz IM, Cañuelo A, Gutierrez F, Gonzalez-Garcia J, Vidal F, Moreno S.

    Shorter Telomere Length Predicts Poorer Immunological Recovery in Virologically Suppressed HIV-1-Infected Patients Treated With Combined Antiretroviral Therapy

    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES . 68(1): 21-29. Nº de citas: 27

    [doi:10.1097/QAI.0000000000000398]

  • Casado JL, Machuca I, Bañón S, Moreno A, Moltó J, Rodriguez MA.

    Raltegravir plus two nucleoside analogues as combination antiretroviral therapy in HIV-infected patients who require cancer chemotherapy

    ANTIVIRAL THERAPY . 20(7): 773-777. Nº de citas: 11

    [doi:10.3851/IMP2961]

  • Casado JL, Bañón S, Rodriguez MA, Moreno A, Moreno S.

    Efficacy and pharmacokinetics of the combination of etravirine plus raltegravir as novel dual antiretroviral maintenance regimen in HIV-infected patients

    ANTIVIRAL RESEARCH . 113: 103-106. Nº de citas: 13

    [doi:10.1016/j.antiviral.2014.11.006]

  • Schlagenhauf P, Weld L, Goorhuis A, Gautret P, Weber R, von Sonnenburg F, Lopez-Vélez R, Jensenius M, Cramer JP, Field VK, Odolini S, Gkrania-Klotsas E, Chappuis F, Malvy D, van Genderen PJ, Mockenhaupt F, Jauréguiberry S, Smith C, Beeching NJ, Ursing J, Rapp C, Parola P, Grobusch MP.

    Travel-associated infection presenting in Europe (2008-12): an analysis of EuroTravNet longitudinal, surveillance data, and evaluation of the effect of the pre-travel consultation

    LANCET INFECTIOUS DISEASES . 15(1): 55-64. Nº de citas: 191

    [doi:10.1016/S1473-3099(14)71000-X]